Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
A Phase 2C Randomized, Controlled, Open-Label Trial of Novel Shortened Regimens for the Treatment of Isoniazid-Monoresistant TB (IMR-TB)

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · United States · $2.57M USD

Grant Information

Provide details about the grant you are applying for


$
Applicant Information

Tell us about yourself and your organization


$
Proposal & Supporting Documents

Provide additional details and upload your proposal document


Accepted formats: PDF, DOC, DOCX. Max size: 10MB